高危女性胎盘植入谱系疾病的超声或磁共振成像诊断:系统评价与Meta分析
该系统评价与Meta分析纳入17项观察性研究、1301名有胎盘植入谱系疾病(PAS)危险因素且同时接受超声和MRI检查的女性,其中457例经术中或组织病理学确诊PAS。超声敏感度0.833、特异度0.834,MRI敏感度0.838、特异度0.831,两种方法间无统计学显著差异,但研究间异质性高。作者认为,在高危人群中,初始筛查影像方法的选择应取决于设备可及性和检查者专业水平。
要点
- 超声诊断PAS敏感度0.833(95%CI 0.776-0.878)、特异度0.834(95%CI 0.746-0.897)。
- MRI诊断PAS敏感度0.838(95%CI 0.786-0.879)、特异度0.831(95%CI 0.770-0.878)。
- 超声与MRI诊断准确度相似,二者间无统计学显著差异。
核心结论
- 超声与MRI诊断PAS的准确度相似,在高危因素高流行环境中,初始筛查影像方法的选择应取决于设备可及性与检查者专业水平。
研究设计与样本
- 遵循Cochrane诊断试验准确性评价指南的系统评价与Meta分析,检索PubMed、EMBASE、PMC、Cochrane Library和BVS-Bireme五个数据库,最终纳入17项观察性研究、1301名同时有MRI和超声数据的女性。
主要发现
- 研究人群包括457例经金标准(术中或组织病理学分析)诊断的PAS病例。
- 超声敏感度0.833(95%CI 0.776-0.878)、特异度0.834(95%CI 0.746-0.897)。
- MRI敏感度0.838(95%CI 0.786-0.879)、特异度0.831(95%CI 0.770-0.878)。
- 两种方法间无统计学显著差异;Cochran Q值提示超声和MRI的敏感度与特异度在研究间存在高水平异质性。
关键数值与推荐
- 纳入标准为2011至2021年以英文发表、评估有PAS危险因素且同时接受超声和MRI检查女性诊断准确度的观察性研究。
- 采用QUADAS-2评价研究质量,所评价研究的总体质量被认为令人满意。
临床怎么用
- 作者认为,在高危因素高流行的环境中,PAS初始筛查影像方法的选择应取决于设备可及性和检查者专业水平。
局限性
- Cochran Q值提示超声和MRI的敏感度与特异度在研究间存在高水平异质性。
- 原文未报告异质性I²数值、发表偏倚检验结果及具体单中心或回顾性设计等局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To perform a systematic review and meta-analysis of the diagnostic test accuracy of ultrasound and magnetic resonance imaging (MRI) and compare the performance of the two modalities in the diagnosis of placenta accreta spectrum (PAS). METHODS: This was a systematic review conducted following the Cochrane Diagnostic Test Accuracy Reviews guideline. A literature search was performed in five databases: PubMed, EMBASE, PMC, The Cochrane Library and BVS-Bireme between 27 July and 4 August 2020. The search was updated on 18 August 2021. We included observational studies evaluating diagnostic accuracy in women with risk factors for PAS who had undergone both ultrasound and MRI examinations, published in English between 2011 and 2021. Quality Assessment of Diagnostic Accuracy Studies-2 was used to evaluate the quality of the studies. Forest plots for sensitivity and specificity with 95% CIs and receiver-operating-characteristics curves for ultrasound and MRI were constructed. RESULTS: The literature search identified 266 studies. After reviewing the titles and abstracts of the articles, 51 were selected for full-text review and 17 studies including 1301 women with MRI and ultrasound data available were selected for the meta-analysis. The study population included 457 cases with PAS diagnosed using the gold standard method (intraoperative or histopathological analysis). The overall quality of the evaluated studies was considered satisfactory according to QUADAS-2. The meta-analysis revealed a sensitivity of 0.833 (95% CI, 0.776-0.878) and specificity of 0.834 (95% CI, 0.746-0.897) for ultrasound. For MRI, sensitivity was 0.838 (95% CI, 0.786-0.879) and specificity was 0.831 (95% CI, 0.770-0.878). There was no statistically significant difference between the two modalities. The Cochran's Q values indicated a high level of heterogeneity of sensitivity and specificity of ultrasound and MRI across studies. CONCLUSIONS: Ultrasound and MRI have similar accuracy in the diagnosis of PAS. These results suggest that, in a setting with a high prevalence of risk factors, the choice of imaging modality for initial screening for PAS should depend on the availability of equipment and the examiner's expertise. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, et al. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 35041250. doi:10.1002/uog.24861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。